Randomized, Open Label, Two Parallel Arms, Intervention Trial Comparing the Effect of DPP-IV Inhibitor Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number in Patients With Type 2 Diabetes in Metformin Failure
Phase of Trial: Phase III
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Glibenclamide (Primary) ; Vildagliptin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms DPP-IVEPC
- 30 Jun 2016 Status changed from not yet recruiting to completed.
- 10 Aug 2013 New source identified and integrated (European Clinical Trials Database; EudraCT2012-005399-32).
- 10 Apr 2013 New trial record